missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Rekombinante Proteine
  4. 18333153

R&D Systems™ PLCL2 Recombinant Protein Antigen

Artikelnummer. 18333153
Ansicht ändern
Click to view available options
Menge:
100 μg
Packungsgröße:
100 Mikroliter
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Artikelnummer. Menge Packungsgröße
18333153 100 μg 100 Mikroliter
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Dieser Artikel kann nicht zurückgegeben werden. Rückgaberichtlinie anzeigen
Artikelnummer. 18333153 Lieferant R&D Systems™ Lieferanten-Nr. NBP317912PEP
 Eingeschränkter Artikel
Verfügbar ab: 25-01-2027
Zum Warenkorb hinzufügen
Zum Warenkorb hinzufügen

missing translation for 'validMainframeMsg'

Dieser Artikel kann nicht zurückgegeben werden. View return policy

Description

A Novus product, part of R&D Systems. Recombinant Protein

TRUSTED_SUSTAINABILITY

Specifications

Zur Verwendung mit (Anwendung) Antibody Competition
Zusammensetzung PBS and 1M Urea, pH 7.4.
Gen-ID (Entrez) 23228
Molekulargewicht M.W. Theoretical: 25 kDa
Menge 100 μg
Lagerungsbedingungen Store at -20°C. Avoid freeze-thaw cycles.
Gen-Alias EC 3.1.4.11, FLJ13484, inactive phospholipase C-like protein 2, KIAA1092PLCE2, phospholipase C, epsilon 2, Phospholipase C-epsilon-2, Phospholipase C-L2, phospholipase C-like 2, PLC-epsilon-2, PLC-L(2), PLC-L2
Gensymbol PLCL2
Forschungskategorie Signal Transduction
Produktlinie Novus
Reinheits- oder Qualitätsgrad >80% by SDS-PAGE and Coomassie blue staining
Protein PLCL2
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.